Hemodynamic and coronary effects of intravenous eletriptan, a 5HT(1B/1D)-receptor agonist

Clinical Pharmacology and Therapeutics

Volumn 66, Issue 1, 1999, Pages 85-90

  Muir, Douglas F ^a,b   McCann, Gerald P ^a   Swan, Lorna ^a   Clark, Andrew L ^a   Hillis, W Stewart ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELETRIPTAN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; DRUG BLOOD LEVEL; DRUG SELECTIVITY; FEMALE; HEART CATHETERIZATION; HEART OUTPUT; HEMODYNAMIC MONITORING; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MALE; MIGRAINE; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE;

ADULT; AGED; CORONARY VESSELS; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INDOLES; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PYRROLIDINES; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; TIME FACTORS; TRYPTAMINES;

EID: 0032797033     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(99)70057-3     Document Type: Article

References (18)

1. 1. Silberstein SD, Liplon RB. Epidemiology of migraine. Neuroepidemiology 1993;12:179-94.
2. 2. Bates D, Bradbury P, Capildeo R. The impacts of migraine. Migraine management guidelines: a strategy for the modern management of migraine. Richmond, England: Synergy Medical Education; 1997. p. 3-4.
3. 1-like receptor agonist, for the acute treatment of severe migraine. Lancet 1988;1:1309-11.
4. 1-like receptor in dog isolated saphenous vein. Br J Pharmacol 1988;94:1123-32.
5. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol 1989;96:434-49.
6. 1 agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol 1992;34:541-6.
7. 1 agonist, on the systemic, pulmonary and coronary circulation. Circulation 1993;87:401-5.
8. 1-receptor agonist. Br J Clin Pharmacol 1997;43:327-8.
9. 1 agonist BMS-180048: a class effect of the triptans? Br J Clin Pharmacol 1999;47:189-94.
10. 10. Houghton LA, Foster JM, Whorwell PJ, Morris J, Fowler P. Is chest pain after sumatriptan oesophageal in origin? Lancet 1994,344:985-6.
11. 11. Willet F, Curzen N, Adams J, Armitage M. Coronary vasospasm induced by subcutaneous sumatriptan. Br Med J 1992;304:1415.
12. 12. Curtin T, Brooks AP, Roberts JA. Cardio-respiratory distress after sumatriptan given by injection. Br Med J 1992;305:713-4.
13. 1D-like" receptor [abstract]. Cephalalgia 1996;16:386.
14. 14. Chahine RA, Raizner AE, Ishimori T, Luchi RJ, McIntosh HD. The incidence and clinical implications of coronary artery spasm. Circulation 1975;52:972-8.
15. 1Dα receptor subtype expression in canine large coronary arteries and saphenous vein. Cardiovasc Res 1996;31:793-9.
16. 1Dβ receptor mediates the super-sensitivity of isolated coronary artery to serotonin in variant angina. Chest 1998;113:243-4.
17. 17. Lipton RB on behalf of the Eletriptan Steering Committee. The clinical experience with eletriptan for the treatment of acute migraine [abstract]. Headache 1997;37:320.
18. 18. British National Formulary. Wallingford, England: Pharmaceutical Press; 1998.